KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Diebold Nixdorf (DBD) Cash & Equivalents (2016 - 2025)

Diebold Nixdorf's Cash & Equivalents history spans 17 years, with the latest figure at $387.3 million for Q4 2025.

  • For Q4 2025, Cash & Equivalents rose 24.41% year-over-year to $387.3 million; the TTM value through Dec 2025 reached $387.3 million, up 24.41%, while the annual FY2025 figure was $387.3 million, 24.41% up from the prior year.
  • Cash & Equivalents reached $387.3 million in Q4 2025 per DBD's latest filing, up from $246.1 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $504.6 million in Q2 2023 to a low of $128.4 million in Q3 2022.
  • Average Cash & Equivalents over 5 years is $286.4 million, with a median of $276.7 million recorded in 2024.
  • Peak YoY movement for Cash & Equivalents: crashed 54.15% in 2021, then surged 192.91% in 2023.
  • A 5-year view of Cash & Equivalents shows it stood at $388.9 million in 2021, then decreased by 17.95% to $319.1 million in 2022, then grew by 17.86% to $376.1 million in 2023, then decreased by 17.23% to $311.3 million in 2024, then grew by 24.41% to $387.3 million in 2025.
  • Per Business Quant, the three most recent readings for DBD's Cash & Equivalents are $387.3 million (Q4 2025), $246.1 million (Q3 2025), and $279.2 million (Q2 2025).